Latest Advances in the Diagnosis and Management of Vitreo-Retinal Disorders

Dear Colleagues,

In recent years, the management of retinal and choroidal diseases has undergone major advances in diagnosis and treatment. In the area of diagnosis, the past two decades have seen significant advances in optical coherence tomography (OCT) as well as OCT angiography and color scanning laser ophthalmoscopy, which have become popular worldwide. Thus, multimodal imaging has improved the accuracy of diagnosis and understanding of pathological conditions. The increase in testing equipment also means an increase in the number of images of healthy and diseased eyes.

Treatment for diseases has also evolved dramatically. No one would dispute that the first of these are anti-vascular endothelial growth factor (VEGF) drugs. Anti-VEGF drugs have become a mainstay in the treatment of retinal diseases such as age-related macular degeneration (AMD), diabetic retinopathy, and macular edema and have greatly expanded the potential of drug therapy for these diseases.

This Special Issue invites a wide range of research related to ophthalmic diagnosis and management. Our aim is for this issue to be of help in the diagnosis and management of vitreo-retinal disorders and to assist in your future research.

Prof. Dr. Takeshi Iwase
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.